NFA Notice I-11-22 Amendments to the Interpretive Notice entitled NFA Compliance Rule 2-9: FCM and IB Anti-Money Laundering Program become effective on January 3, 2012. The amendments incorporate changes made by the Financial Crimes Enforcement Network to the regulations of the Bank Secrecy Act relating to suspicious activity reports, provide Members with additional guidance with respect to the annual training and independent audit requirements and make several other technical changes which conform the Notice to specific requirements in the BSA. Cross References: NFA Compliance Rule 2-9; NFA's

Testimony of CFTC Chairman Gensler Chairman Gensler recites his standard testimony declaring that because three years ago the "the financial system failed, and the financial regulatory system failed as well," Dodd-Frank reform and greater CFTC resources are necessary. He also states that: "The CFTC is working to complete our rule-writing under the Dodd-Frank Act thoughtfully - not against a clock." The testimony also outlines the agency's phased-in implementation of the Act.

11-06 The CFTC's Office of General Counsel issued a "no-action" letter in connection with the offer and sale in the United States of Euronext Brussels, S.A.'s futures contract based on the BEL 20 Index. Cross References: CEA Section 2(a); CFTC Rule 41.13; 17 CFR Part 30.

11-07 The CFTC's Office of General Counsel issued a "no-action" letter in connection with the offer and sale in the United States of TAIFEX's futures contract based on the Gretai Securities Market Capitalized Weighted Stock Index Cross References: CEA Section 2(a); CFTC Rule 41.13; 17 CFR Part 30.

76 FR XXXX The CFTC is proposing rules that would establish a process for Designated Contract Markets and Swap Execution Facilities to make a swap "available to trade" as set forth in Section 2(h)(8) of the CEA pursuant to Section 723 of the Dodd-Frank Act. The proposed rules provide that DCMs and SEFs make the determination of when a swap has been made available to trade by considering seven enumerated factors, or any other factor that the DCM or SEF may view as relevant. The rules provide that the DCM or SEF may either certify the determination or seek approval under the Commission's part 40